The UVA/PADOVA type 1 diabetes simulator: New features

Journal of Diabetes Science and Technology

Volumn 8, Issue 1, 2014, Pages 26-34

  Dalla Man, Chiara ^a   Micheletto, Francesco ^a   Lv, Dayu ^b   Breton, Marc ^b   Kovatchev, Boris ^b   Cobelli, Claudio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Computer simulation; Diabetes control; Modeling

Indexed keywords

ANTIDIABETIC AGENT; GLUCAGON; INSULIN;

ARTICLE; COMPUTER MODEL; COMPUTER SIMULATION; DIABETES CONTROL; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; KINETICS; SIMULATOR;

EID: 84899101145     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296813514502     Document Type: Article

References (28)

1. Cobelli C, Dalla Man C, Sparacino G, Magni L, De Nicolao G, Kovatchev BP. Diabetes: models, signals, and control. IEEE Rev Biomed Eng. 2009;2:54-96.
2. Cobelli C, Renard E, Kovatchev B. Artificial pancreas: past, present, future. Diabetes. 2011;60:2672-2682.
3. Hovorka R, Chassin LJ, Wilinska ME, et al. Closing the loop: the adicol experience. Diab Technol Therap. 2004;3:307-318.
4. Kovatchev BP, Breton M, Dalla Man C, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3(1):44-55.
5. Visentin R, Dalla Man C, Kovatchev BP, Cobelli C. Incorporating nonlinear response to hypoglycemia into the type 1 diabetes simulator. Paper presented at: 11th Diabetes Technology Meeting; October 27-29, 2011; San Francisco, CA.
6. Chan A, Heinemann L, Anderson S, Breton MD, Kovatchev BP. Nonlinear metabolic effect of insulin across the blood glucose range in patients with type 1 diabetes mellitus. J Diabetes Sci Technol. 2010;4:873-881.
7. Micheletto F, Dalla Man C, Breton MD, Kovatchev BP, Cobelli C. A counter-regulation model in type 1 diabetes. Paper presented at: 11th Diabetes Technology Meeting; October 27-29, 2011; San Francisco, CA.
8. Dobbins RL, Davis SN, Neal DW, Cobelli C, Jaspan J, Cherrington AD. Compartmental modeling of glucagon kinetics in the conscious dog. Metabolism. 1995;44:452-459.
9. Kovatchev BP, Farhy LS, Cox DJ, et al. Modeling insulin-glucose dynamics during insulin induced hypoglycemia. Evaluation of glucose counterregulation. J Theor Med. 1999;1:313-323.
10. Kovatchev BP, Straume M, Farhy LS, Cox DJ. Dynamic network model of glucose counterregulation in subjects with insulin-requiring diabetes. In: Johnson M, Brand L, eds. Methods in Enzymology, 321: Numerical Computer Methods, Part C. New York, NY: Academic Press; 2000:396-410.
11. Kovatchev BP, Straume M, Cox DJ, Farhy LS. Risk analysis of blood glucose data: a quantitative approach to optimizing the control of insulin dependent diabetes. J Theor Med. 1999;3:1-10.
12. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979;236(6):E667-E677.
13. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med. 2010;2(27):27ra27.
14. Lv D, Breton MD, Farhy LS. Pharmacokinetics modeling of exogenous glucagon in type 1 diabetes mellitus patients. Diabetes Technol Ther. 2013;15(11):935-941.
15. Lorenzi M, Bohannon N, Tsalikian E, et al. Duration of type 1 diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia. West J Med. 1984;141:467-471.
16. Siafarikas A, Johnston RJ, Bulsara MK, et al. Early loss of glucagon response to hypoglycemia in adolescents with type 1 diabetes. Diabetes Care. 2012;35(8):1757-1762.
17. Sjöberg A, Ahren B, Bolinder J. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes. J Intern Med. 2002;252:342-351.
18. Bruno G, Runzo C, Cavallo-Perin P, et al. Incidence of type 1 and type 2 diabetes in adults aged 30-49 years. Diabetes Care. 2005;28:2613-2619.
19. Felner EI, Klitz W, Ham M, et al. Genetic interaction among three genomic regions creates distinct contributions to early-and late-onset type 1 diabetes mellitus. Pediatr Diabetes. 2005;6:213-220.
20. Laakso M, Pyörälä K. Age of onset and type of diabetes. Diabetes Care. 1985;8(2):114-117.
21. Karjalainen J, Salmela P, Ilonen J, et al. A comparison of childhood and adult type 1 diabetes mellitus. N Engl J Med. 1989;320(14):881-886.
22. Tenconi MT, Devoti G, Albani I, et al. IDDM in the province of Pavia, Italy, from a population-based registry. Diabetes Care. 1995;18(7):1017-1019.
23. Hinshaw L, Dalla Man C, Nandy DK, et al. Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes. 2013;62(7):2223-2229.
24. Warshaw H, Bolderman KM. Practical Carbohydrate Counting: A How-to-Teach Guide for Health Professionals. Alexandria, VA: American Diabetes Association; 2001.
25. Walsh J, Roberts R. Setting and testing your carb boluses. In: Torrey Pines Press, ed. Pumping Insulin. Everything You Need for Success with an Insulin Pump. 3rd ed. San Diego, CA: Torrey Pines Press; 2000:105-113.
26. Bolderman KM. Prepping pump patients. In: American Diabetes Association, ed. Putting Your Patients on the Pump. Alexandria, VA: American Diabetes Association; 2002:19-38.
27. Davidson PC, Hebblewhite HR, Bode BW, et al. Statistically-based CSII parameters: correction factor, CF (1700 rule), carbohydrate-insulin ratio, CIR (2,8 rule), and basal-to-total ratio (abstract). Diabetes Technol Ther. 2003;5(2):237.
28. Magni L, Raimondo DM, Dalla Man C, et al. Evaluating the efficiancy of closed-loop glucose regulation via control-variability grid analysis (CVGA). J Diabetes Sci Technol. 2008;2:630-635.